Common malignant brain tumors: can 18F-FDG PET/CT aid in differentiation?
Conclusion: Central nervous system lymphomas can be differentiated from GBM and metastases by their higher metabolic activity. In addition, 18F-FDG PET/CT can potentially impact therapeutic decisions by detecting primary malignancy in patients with metastatic brain lesions and extracranial disease sites in patients with brain lymphoma.
Source: Nuclear Medicine Communications - Category: Nuclear Medicine Tags: Original Articles Source Type: research
More News: Brain | Brain Cancers | Brain Tumor | Cancer | Cancer & Oncology | CT Scan | Lung Cancer | Lymphoma | Neurology | Nuclear Medicine | PET Scan | Primary CNS Lymphoma | Statistics | Study